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ABSTRACT
Brockman, Trisha Lynn. M.S., Department of Biological Sciences, Wright State
University, 2014.
Binding and entry mechanisms of adenovirus in polarized epithelial cells.
Adenovirus’s primary receptor, the Coxsackievirus and adenovirus receptor
(CAR), has two transmembrane isoforms with differential localization within polarized
epithelial cells (CAREx7 (basolateral), CAREx8 (apical)). I hypothesized that each isoform
of CAR is degraded at different rates and is regulated by Src-family kinases. Increasing
or decreasing the concentration of CAR is predicted to directly alter adenoviral entry. To
test this hypothesis, inducible Madin Darby Canine Kidney (MDCK) cell lines either
expressing CAREx7, CAREx8, or mCherry, under a doxycycline-inducible promoter were
used in pulse-chase structured experiments to calculate the half-lives of these proteins.
Alternatively, a polarized model lung epithelium (CaLu-3) treated with Src-kinase
inhibitor, PP2, was used to test apical CAREx8 expression and viral transduction. Though
CAREx7 and CAREx8 did have varying half-lives (5.1 h, 2.0 h respectively), inhibiting
Src-family kinases did not decrease CAREx8 expression at early time points but did
diminish adenovirus transduction. These data confirm that Src does not play a role in
CAR turnover, but remains critical for adenoviral infection.
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CHAPTER 1. INTRODUCTION
	
  
1.1 Adenovirus
Adenoviruses are respiratory pathogens that threaten the health of both civilian
and military populations, causing up to 5-10% of reported “common cold” cases [1].
Adenovirus infections can cause gastroenteritis, conjunctivitis, cystitis, and respiratory
distress.

Typically in healthy individuals, adenovirus infections are self-resolving,

however, in more severe cases such as immunocompromised individuals, adenovirus
infections can result in the onset of acute respiratory disease and even death [2].
Adenoviruses are non-enveloped viruses containing a 36 kb linear double
stranded DNA genome (Fig. 1). Upon infection, adenoviruses genome does not integrate
into the host genome. It is due to this lack of genomic integration between virus and host
that makes adenoviruses a potential and ideal vector for gene therapy. Currently, the
pitfall with using adenovirus as a vector to mediate gene therapy within the lung is the
inability for the virus to infect host cells efficiently [3].
Receptor abundance and accessibility help to determine the tropism and
pathogenicity of a virus [3-5]. Viral infection occurs after the initial binding of the virus
to its primary receptor on the target cell of the host. The more accessible a receptor is to a
virus, the greater the chance of infection. If the primary receptor is inaccessible to the
virus, then viral infection is prohibited, as is the case for adenovirus in the lung
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Figure 1. Structure of adenovirus.
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epithelium [3]. Most adenoviruses co-opt host epithelia by binding to the Coxsackievirus
and Adenovirus Receptor (CAR), their primary receptor [6]. The fiber-knobs of
adenovirus bind tightly to CAR in the initial virus attachment step, while integrins
facilitate adenoviral entry upon binding the penton base (Fig. 1) [7]. However, tissues
lacking CAR expression show resistance to adenovirus infection, even in the presence of
integrins, demonstrating that CAR is crucial for the binding of adenovirus to the host cell
[5, 8]. Therefore the presence or absence of CAR can greatly alter host susceptibility to
adenoviral infection. Adenoviral binding and entry has been widely studied in nonpolarized cells; however the mechanism for apical infection of polarized epithelia is only
beginning to be elucidated.

1.2 Coxsackievirus and adenovirus receptor (CAR)
The coxsackievirus and adenovirus receptor is the primary receptor for most
adenoviruses and can function as an attachment site for adenovirus serotypes from
subgroups A, C, D, E, F, and G [1, 6]. CAR abundance has been closely associated with
efficient adenovirus transduction [9-12].
CAR is a single pass type I transmembrane glycoprotein composed of two
extracellular immunoglobulin domains (D1 and D2), a single hydrophobic α-helical
transmembrane domain, and an intracellular region [6]. In polarized epithelial cells the
extracellular immunoglobulin domain, D1, of CAR is involved in homophilic cell-cell
adhesion and tissue genesis [11, 13-16]. CAR-CAR homophilic interactions between
epithelial cells are crucial for maintaining tissue integrity in the heart and in the tight
junctions of polarized epithelia. CAR-CAR interactions are so important in establishing
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tissue polarity that the knockout of CAR is embryonically lethal at approximately day 10
of gestation due to loss of intercalated disc formation in the heart [16]. The D1 domain
of CAR is not only responsible for homophilic interactions, but forms heterophilic
interactions with the leukocyte-specific protein junction adhesion molecule like (JAM-L).
CAR is also the attachment site of the adenovirus fiber knob [17, 18] and is involved in
CAR dependent cell-cell communication [12, 19].
In the past, two main protein isoforms of CAR have been described: CAREx7 and
CAREx8. These isoforms result from the alternative splicing of the mRNA encoded by the
CXADR gene (Fig. 2) [9]. The CAREx7 spliceform is a result of mRNA splicing that
terminates at the end of the seventh exon of CXADR. The CAREx8 spliceform is a result
of splicing of the mRNA from a cryptic splice site within the middle of the seventh exon
of CXADR to the eighth exon and terminates at the end of exon 8, thus leading to two
distinct mRNAs that encode proteins with unique C-termini. The protein structure of
CAREx7 and CAREx8 are identical except for the last 26 (CAREx7) or 13 (CAREx8) amino
acids (aa) of the intracellular C-terminus [9].
The most abundant isoform of CAR (CAREx7) localizes to the basolateral surface
of polarized epithelial cells beneath the tight junctions, where it is inaccessible to
adenovirus (Fig. 3A) [9, 11, 20]. An outstanding question has been how people become
initially infected with an adenovirus entering from the airway lumen if the primary
receptor is sequestered at the basolateral surface.

Several mechanisms have been

proposed: 1) a breach in the epithelial barrier by way of a transient or sustained break in
the tight junctions; 2) the binding of adenovirus to a secondary receptor (e.g. αVβ3
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Figure 3. Accessibility of CAR to adenovirus entering from the lumen of the
Ex7
airway. A. CAR localizes beneath the tight junctions at the basolateral surface of
polarized epithelia. This results in the absence of receptor on the apical surface;
Ex8
therefore, no infection takes place. B. CAR
at the apical surface allows for
adenovirus internalization and infection of cells from the airway lumen.
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and αVβ5 integrins); 3) cytokines released upon infection of resident host macrophages
promote infection of the airway epithelia; or 4) increased apical abundance of CAR [21].
Recently, Excoffon et al., 2010 have described an alternative low abundance
isoform of CAR (CAREx8) that is spliced to include an eighth exon [9]. CAREx8 localizes
at the apical surface or just beneath the apical surface in the subapical compartments
(SAC) of polarized airway epithelia (Fig. 3B). CAREx8 has been shown to act as a
receptor for adenovirus and is able to mediate viral infection from the apical surface of
polarized epithelia. Endogenous CAREx8 abundance at the apical surface of polarized
epithelia appears to be sufficient to media viral infection; however, the protein is found in
such low abundance that viral infection remains low. Increasing the amount of CAREx8 at
the apical surface has been shown to increase viral transduction efficacy [9, 22]. This
suggests that gene therapy efficacy or, alternatively, host susceptibility to adenoviral
infection can be altered by manipulating the levels of apical CAREx8. My thesis is focused
on understanding the endogenous regulation and turnover of the CAREx8 isoform.

1.3 Protein turnover
Half-life refers to the amount of time it takes for half of the protein synthesized
within a certain period of time to reach one half of its original concentration within the
cell. Half-lives are unique for every protein. Some may be long, such as articular
cartilage collagen, with a half-life of ~117 years [23]. Others are short, such as ornithine
decarboxylase, with a half-life of 11 min [24]. The half-life can vary even between two
different isoforms of the same protein. For example, murine Sirt3 protein has three
known isoforms each with variable half-lives [25]. Half-lives are also affected by post-
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translational modifications and interactions. Proteins are broken down by proteolysis,
which results in smaller polypeptides or individual amino acids. Proteolysis is involved
in the regulation of some physiological and cellular processes preventing the
accumulation of regulatory, unwanted, or abnormal proteins. Proteins are degraded in the
lysosome, proteasome, or by autophagy. Degradation in the proteasome is generally
considered a ubiquitin-dependent process [26].
Knowing the turnover rate of a protein within a cell can aid in both the
understanding and identification of how that protein is regulated. Little is known about
the regulation of CAREx8 in the cell. Identifying the half-life of CAREx8 as well as the
turnover rate of CAREx8 at the apical surface of polarized epithelia will be one of the first
steps in determining the mechanisms by which CAREx8 is regulated. Understanding how
CAREx8 is regulated will help to decipher why some tissues may be more susceptible to
adenovirus infection than others.

Knowing how long it takes for a protein to be

synthesized and degraded will aid in identifying critical time frames in which clinicians
can transiently overexpress CAREx8 for optimal gene therapy with an adenovirus vector
without increasing the patient’s susceptibility to wild type adenovirus or suppressing
other immunological functions.

1.4 Src-family kinases:
The Excoffon lab has shown that the C-terminal sequence difference between the
two isoforms of CAR results in their differential localization in polarized cells [9, 22].
Much is known about how CAR interacts with adenovirus [7]. In contrast, fewer studies
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have been directed towards unraveling the native biological function of CAR and its
regulation.
The variance between the cytoplasmic tails of the two specified isoforms of CAR
contains potential sites for differential phosphorylation. Phosphorylation of a protein is a
posttranslational regulatory modification, wherein serine (S), threonine (T), or tyrosine
(Y) residues are covalently linked to a phosphate group. Protein phosphorylation is
performed by proteins known as kinases, which add phosphate groups, and is reversed by
phosphatases, which remove phosphate groups. Phosphorylation is known to alter the
localization, behavior, and often, interactions between proteins. The C-terminus of CAR
contains several putative phosphorylation sites [27, 28] . The variations of amino acids
between the C-terminus of CAREx7 and CAREx8 are likely to be the distinguishing factor
between the regulation of the two isoforms, resulting in the apical localization of CAREx8.
Recently, Src-family kinases (SFK), a group of non-receptor tyrosine kinases
made up of nine family members, c-Src, Lck, Hck, Fyn, Frk, Yes, Blk, Lyn, and Fgr,
have been shown to play a role in viral infections [21, 29-32]. Mainou and Dermody
showed that reovirus infection decreased when Src-family kinases were inhibited [32].
They concluded that Src-family kinases help traffic internalized viruses to the
endosomes, however, when Src-family kinases were inhibited, the internalized virus was
sent to the lysosome for degradation thus resulting in decreased reovirus infection.
Similarly, Lütschg et al., 2011 saw decreased adenovirus infection when Src-family
kinases were inhibited [21]. They attributed decreased adenovirus infection to decreased
αvβ3 integrin expression (a secondary receptor for adenovirus) at the apical surface of the
epithelia. Following in suit, a similar decrease in coxsackie B virus infection was seen
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with Src-family kinase inhibition of intestinal epithelial cells [29] and placental
trophoblasts [31]. Inhibiting Src-family kinases potentially plays several roles in viral
infection: 1) decreased receptor abundance or localization; 2) inhibits viral
internalization; or 3) alters trafficking and processing of the virus.
In a recent study, Mruk et al. proposed a novel regulatory protein complex
containing desmoglein-2, desmocollin-2, zona occludin-1 (ZO-1), c-Src, and CAR at the
cell-cell interface of sertoli germ cells [33]. When both desmoglein-2 and desmocollin-2
were knocked down, there was a mislocalization of c-Src, CAR, and ZO-1 at the tight
junctions resulting in weak cell-cell adhesion. They were also able to show that CAR and
c-Src co-immunoprecipitate together. These data suggest that CAR may be regulated by
c-Src or, alternatively, CAR may regulate c-Src in some way.
In this thesis, my focus is to analyze the pathways that Src-family kinases use to
regulate CAR expression at both the basolateral and apical surface of polarized epithelial
cells and how this affects adenovirus sorting upon apical entry.

1.5 Rationale
It is important to study the regulation of CAR and the mechanisms governing
adenovirus entry in order to advance adenovirus-mediated gene therapy, which is
hindered due to the limited accessibility of apical CAR to adenoviruses entering the
airspace or lumen of the airway epithelium. Mechanisms that result in increased primary
receptor concentrations will increase the clinical efficacy of adenovirus-based gene
therapy techniques. Conversely, it is unclear what increases the susceptibility of the
airway to pathogenic adenovirus infection. Mechanisms that result in decreased primary
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receptor concentrations will decrease the susceptibility of an individual to adenovirus
infection and reduce the spread of wild type adenovirus either within vulnerable
populations or during an outbreak of a highly virulent adenoviral strain.

1.6 Hypotheses and specific aims
The ultimate goal is to better understand the endogenous mechanisms that
regulate both CAREx7 and CAREx8 expression, abundance, localization, and degradation
in polarized epithelial cells and how this alters adenoviral infection. I hypothesize:
CAREx8 is tightly regulated by Src-family kinases and maintains a shorter half-life than
CAREx7.
Here, in these studies, I have taken an investigative approach to studying CAR
expression and adenoviral transduction using polarized epithelial cells (MDCK stable cell
lines (doxycycline-induced to express CAREx7, CAREx8, or mCherry); CaLu-3 cells). The
chosen cell lines are ideal models for these studies due to three distinguishing properties:
all are epithelial cell lines expressing endogenous CAR(Ex7

and Ex8)

, all are capable of

polarizing, and all can be manipulated by standard molecular procedures (Fig. 4).
Although many studies have been done with CAR, the half-life of CAR as well as the
half-life of its specified isoforms remains a mystery. Moreover, the inhibition of Srcfamily kinases (SFK) has recently been shown to decrease adenovirus, coxsackie B virus,
and reovirus infection in epithelial cells, however, the mechanisms remain unclear [21,
29, 32] .
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In these aims I Aim 1.) determine the half-life of CAREx7 and CAREx8. Aim 2.)
determine whether the inhibition of Src-family kinases alters adenoviral infection by
interfering with the protein expression and localization of CAREx8.
These aims will begin to address how CAREx8 is regulated within the cell and how
adenoviruses can take advantage of the differential regulation between the two specific
isoforms.
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Figure 4. Doxycycline (Dox) inducible MDCK cells able to stably express: A.
Ex8
Ex7
CAR
or B. CAR
as determined by Western blot, relative to the control
housekeeper protein actin, or C. mCherry (a red fluorescent protein), as
observed using a 4x lens on a Nikon fluorescence microscope, upon the addition
of doxycycline.
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Chapter 2. Materials and Methods
2.1 Materials
Antibodies
Anti-actin and -RmcB (anti-CAR; extracellular domain which is identical to both
CAR isoforms) were obtained from Millipore (Bedford, MA), Anti-FLAG was purchased
from Sigma-Aldrich (St Louis, MO). The mouse anti-GFP was from Clontech
(Mountainview, CA). The anti-V5, anti-ZO-1, rabbit anti-GFP, and the fluorescentlylabeled secondary antibodies came from Invitrogen (Carlsbad, CA). Anti-MAGI-1 was
from Novus Biologicals (Littleton, CO). The anti-Src antibodies came from Cell
Signaling (Danvers, MA). Horse-radish peroxidase-labeled secondary antibodies were
obtained from Jackson ImmunoResearch (West Grove, PA). Rabbit anti-CAR-1605
(recognizes the C-terminus in common to both isoforms) and anti-CAREx8-5678 (specific
to the last 13 aa of CAREx8) have previously been described [9].

Cell lines
The three main cell lines used: 1) HeLa cells expressing shRNA for either
scrambled (control; non-specific vector) or c-Src kinase (gift from Dr. Terry Dermody,
Vanderbilt University); 2) MDCK parental cells (ATCC, Rockville, MD) were used to
generate three stable cell lines able to express either FLAG-tagged CAREx7, FLAGtagged CAREx8, or red fluorescent protein mCherry under a doxycycline (Dox) inducible
promoter (24 h, 100 ng/ml Dox for expression) (Fig. 4) using the Lenti-X Tet-On
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advanced inducible expression system (Clontech. Cat no: 632162) according to the
manufacturer’s protocol (produced by Dr. Abimbola Kolawole under the supervision of
Dr. Katherine JDA Excoffon, Wright State University); and 3) CaLu-3 cells (ATCC,
Rockville, MD), were cultured under standard conditions (DMEM (Invitrogen) with 10%
FBS, 1 mM NEAA, 1 mM Sodium Pyruvate, Amphotericin B), (MEM (Invitrogen) with
5% FBS tetracycline negative (PAA Lab, Dartmouth, MA)) or (RPMI1640 (Hyclone)
with 10% FBS, 25 mM HEPES (Hyclone)), and 1% penicillin/streptomycin (Fisher),
respectively.

Viral vectors, chemical inhibitors, and activators
Adenovirus vectors carrying either the β-galactosidase reporter gene (AdV-βGal), or the green fluorescent protein (GFP) reporter gene (AdV-GFP), were from the
University of Iowa Vector Core, Iowa City, IA. The inhibitors and activators used in the
study are listed in Table 1.
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Table 1. List of chemical inhibitors and activators
Inhibitors &
Activators

Target

Vendor

Catalog #

Cycloheximide

Protein synthesis inhibitor

Sigma-Aldrich

C7698-1G

Genistein

Tyrosine protein kinases

Sigma-Aldrich

G6649-5MG

PP1

Src-family kinases

Sigma-Aldrich

P0040-5MG

PP2

Src-family Kinases

Sigma-Aldrich

P0042-5MG

Src-Activator

Src-family kinases

Santa Cruz Biotech

Sc-3052
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2.2 Methods
Cell culture maintenance
Cell culture techniques were performed under a laminar flow hood using sterile,
biohazard level 2+ techniques. Cell cultures were stored and grown in 25- or 75-cm2
tissue culture flasks within a humidified incubator at 37ºC and 5% CO2. Used mediaserum mix was discarded and new media-serum mix was added, based upon a pH change
from 7.1 to about 6.0, as indicated by a color change of the media from pink to yellow or
depending on confluency of cells. As cells began to divide and reached about 80%
confluency, as observed under 400X total magnification with an inverted microscope, the
cell cultures were divided into new flasks using a ratio of between 1:5 and 1:20 cells to
media after removing attached cells with 0.25% Trypsin-EDTA (Mediatech, Inc.,
Manassas, VA). All flasks were supplied with new media-serum mix to a final volume of
5 ml in a 25-cm2 tissue culture flask and 10 ml in a 75-cm2 tissue culture flask. Cell
viability was verified before each experimental set using the trypan blue exclusion test
[34]. Dead cells appeared blue since their membranes had become permeable to the
trypan blue dye. Cell viability above 80% was considered acceptable for use in future
experiments.

Determination of cell concentration (hemocytometry)
The following technique was used during cell seeding before transfections and
adenovirus infections. Adherent monolayers of cells were trypsinized from 1-2 flasks and
combined in a 50 ml centrifuge tube. The tube was centrifuged at 150 rcf for 5 min. at
4ºC. The supernatant was aspirated and the cells were resuspended in 1 ml of culture
medium and mixed gently by pipetting up and down. A clean coverslip was centered on a
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hemocytometer between the outside railings over the two counting grids. A drop of wellmixed cell suspension was placed at each notch. The drop was added once to ensure an
even distribution of cells. Cells were then counted with a push button counter using 400X
total magnification. Cells were counted in the four corner squares (1 mm X 1 mm) of the
cytometer. These squares were 1/400 mm2. The average value of the total cells counted in
the 4 squares was multiplied by 104 to determine the number of cells per milliliter. The
volume of the mixture was adjusted by dilution with culture media to an appropriate
concentration, depending on the demands of the particular assay.

Brightfield and fluorescence microscopy
Brightfield and fluorescence microscopy were used to observe and optimize the
experimental cellular growth conditions for CaLu-3 cell epithelial monolayers that had
either been infected with an adenovirus carrying the green fluorescent protein reporter
gene (AdV-GFP; MOI 100; 1 h) or induced with doxycycline to overexpress the red
fluorescent protein mCherry (MDCK mCherry stable cells; 100ng/ml Dox; 24 h) as a
control for the MDCK stable cell lines. Brightfield and fluorescence images were
obtained from a NIKON Eclipse TE2000-S fluorescent microscope at a magnification of
10X.

Western blot
Cell cultures were placed on ice for 5 min, washed with ice-cold PBS, and lysed
in a buffer solution (50 mM Tris pH 7.4, 150 mM NaCl, 1% Triton X-100, protease
inhibitors (20 µg/ml, leupeptin, aprotinin, 10 µg/ml pepstatin, and 17.4 µg/ml
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phenylmethylsulfonyl fluoride)) by rocking at 4°C for 10 min. Cells were scraped into a
tube, sonicated five times with 5 pulses using a Sonic Dismembrator (Fisher Scientific,
model 100) and centrifuged at 14,000 X g for 10 min at 4°C. The supernatant was
transferred to fresh tubes and subjected to protein estimation by Bio-Rad protein assay
according to the manufacturer’s instructions. Cell lysates were treated with ((1 µL)/(3 µL
lysate)) 4 X denaturing buffer with dye (for WB) and incubated in a heat block at 65°C
with shaking at 300 rpm for 10 min. The samples were then immediately vortexed
vigorously before spinning at 17,000 rcf for 30-60 sec. Cell lysates were subjected to
SDS polyacrylamide gel electrophoresis (SDS-PAGE) (using a 12% polyacrylamide gel
unless otherwise indicated). The proteins on the polyacrylamide gel were transferred to a
polyvinylidene difluoride membrane (PVDF) (Millipore, Bedford, MA), blocked with 5%
BSA in tris-buffered saline tween-20 (TBS-T), washed, and probed with an appropriate
antibody diluted in 5% BSA in TBS-T with sodium azide, followed by probing with
HRP-conjugated secondary antibodies (Jackson Immuno Research, West Grove, PA)
diluted in TBS-T (1:10,000). Protein bands were detected by adding ECL reagents
(Pierce, Rockford, IL) for 1 min and imaged on a Fuji LAS 4000 and/or developed in an
X-ray Medical film processor model Konica SRX 101.

Adenovirus infection
Adenovirus serotype 5 containing the β-galactosidase gene (AdV-β-Gal) or eGFP
(AdV-GFP) driven by the CMV promoter (University of Iowa Vector Core, Iowa City,
IA) was diluted with OptiMem culture media (Gibco, Invitrogen) without serum to the
multiplicity of infection (MOI) of 100 plaque forming units (pfu) per cell. Growth media
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was aspirated from cells that had been seeded for 24 to 48 hours, depending on the
experiment, and the cells were rinsed with phosphate buffered saline containing calcium
and magnesium (PBS+/+). 250 µL of diluted adenovirus was added to each well in a 24well plate (3 ml in 10 cm2 dish) at an MOI of approximately 100 plaque forming
units/cell (PFU/cell), unless otherwise indicated, and incubated for 1 h at 37°C and 5%
CO2 with gentle swirling every 15 min. The inoculum was then removed, cells were
rinsed with OptiMem, and fresh media was added. Cells were incubated at 37°C with 5%
CO2 until further analysis was conducted.

Beta-galactosidase assay
The Galacto-Light Plus System (Applied Biosystems, USA) was used to analyze
adenovirus-mediated beta-galactosidase activity according to the manufacturer’s
directions. Briefly, cells were lysed 24 hours after infection with an adenovirus carrying
the β-galactosidase reporter gene (AdV-β-Gal). 120 µL of lysis buffer was added to each
well in a 24-well plate for 20 min at room temperature. Cells were scraped and 2 µL of
lysate was added into a 96-well plate followed by 100 µL of a 100X dilution of GalactonPlus substrate and 60 min incubation at room temperature. Enzyme activity was
terminated in congruence with the light emission of the cleaved substrate being triggered
upon the addition of 150 µL of Accelerator-II immediately before measuring the βgalactosidase luminescence with an Optima Luminometer. Protein concentration was
determined by adding 6 µL of lysate into a cuvette, followed by the addition of 1 ml BioRad reagent diluted (1:10 with double distilled water (ddH2O)). The mixture was
incubated at room temperature for 10 min and the optical density was determined with a

20	
  

	
  

spectrophotometer set to 595 nm, using a standard blank as a programmed baseline. Each
experiment was performed in 4-6 biological replicates and lysis buffer was used as a
negative control. Data were analyzed by the two-tailed Student’s T-test, one-way analysis
of variance (ANOVA), with Tukey’s or Dunnett’s post hoc test (Prism, GraphPad) or as
described in the text.

Cell surface biotinylation
Cell surface proteins were biotinylated with 3 ml per 100 mm plate of 1 mg/ml
sulfo-NHS-biotin (Cat # 21331 Thermo Scientific, Rockford, IL) for 1 h at 4°C after first
cooling the cells on ice for 10 min and washing with ice cold PBS +/+. After washing the
cells again with ice cold PBS +/+, any unreacted biotin was quenched with ice cold 100
mM glycine for 20 min at 4°C. Washed cells were then incubated with lysis buffer for
another 20 min at 4°C. The cell lysate was then immunoprecipitated with NeutrAvidin
ultra link resin (Cat # 53150 Thermo Scientific) and subjected to Western blotting with
an antibody of interest.

Total cellular RNA extraction
Total cellular RNA was extracted from treated and control cells using TRIzol
Reagent (Invitrogen Life Technologies, Carlsbad, CA). Gloves were worn throughout the
experiment with frequent changing and ribonuclease (RNase)-free materials were used in
an RNase-free environment [35, 36]. Cells were centrifuged for 5 min. at 12,000 rcf at
room temperature. The supernatant was discarded. The cells were lysed with 1 ml of cold
Trizol reagent by repeatedly pipetting up and down. The contents of the tube were
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allowed to stand at room temperature for 5 min. to permit the dissociation of
nucleoprotein complexes. Chloroform (0.2 ml) was added to each tube and the tubes were
capped securely. The tubes were shaken vigorously by hand and then allowed to sit for 3
min. at room temperature. The tubes were spun at 12,000 rcf for 15 min. at 4°C. The
aqueous layer, which contains the RNA, was transferred to new centrifuge tubes.
Isopropanol (0.5 ml) was added into each tube. The contents were gently mixed and
incubated at room temperature for 10 min. These were centrifuged at 12,000 rcf for 10
min. at 4°C. The supernatant was aspirated. The RNA pellet was washed with 1 ml 75%
ethanol, vortexed, and centrifuged at 7,500 rcf for 5 min. at 4°C. All of the ethanol was
removed, without drying the RNA pellet completely. The RNA pellet was dissolved in
30% diethyl pyrocarbonate (DEPC)-treated ddH2O by passing the solution through a
pipette tip and incubating for 10 min. at 55-60°C. The solutions were then transferred to
RNase-free Eppendorf tubes. The purity and concentration of the extracted RNA were
determined via nanodrop in CGR (Thermo Scientific). Pure RNA has a 260:280 nm
reading equal to 2.0. The extracted RNA was stored at -80°C.

Polymerase chain reaction (PCR) RT-PCR
The designed primers for the two CAR isoforms and MAGI-1 mRNA were
purchased from Integrated DNA Technologies (Coralville, IA) and used for RT-PCR in a
two-step RT-PCR system (Invitrogen Life Technologies, Carlsbad, CA). RNA samples
taken from the extracted total RNA from each cell line were used as templates for reverse
transcription into cDNA using the reverse transcriptase enzyme (Invitrogen). 1% cDNA
and 10% of each primer were added to 0.2 ml, nuclease-free, thin-walled PCR reaction
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tubes on ice. The reaction mixtures were placed in a preheated and programmed personal
Master Thermal cycler (Eppendorf, Westbury, NY) for gene amplification using Taq
DNA polymerase (New England BioLab Inc. Ipswich, MA). The conditions that were
programmed in the thermal cycler included 1 cycle of incubation for DNA synthesis at
94°C for 2 min. The PCR amplification was programmed for 35 cycles at 94°C for 15 sec
(denaturation), 55oC for 15 sec (annealing), and 72°C for 45 sec (extension). The final
extension cycle was programmed for 5 min. at 72oC.

Regular PCR
This was performed at several instances during the study to confirm correct
inserts during the process of cloning the DNA plasmids, using bacterial colonies as
templates, as described above.

Quantitative PCR (qPCR)
RNA was isolated using TRIzol (Invitrogen). cDNA was synthesized from the
same starting amount of RNA using the Quanta First Strand Kit from Quanta
BioSciences (Gaithersburg, MD). The PCR amplification program for this protocol was
designed to contain 40 cycles at 95oC for 30 sec (denaturation), 58oC for 30 sec
(annealing), and 74°C for 1 min. (extension). The final extension cycle was programmed
for 10 min. at 74°C. qPCR was performed using SYBR Green with low ROX (Quanta,
Gaithersburg, MD; 10% master mix qPCR reaction contained 2 µl cDNA, 2X reaction
buffer with dNTPs, Accusat Taq DNA polymerase, MgCl2 ROX reference dye and
SYBR green dye that binds specifically to dsDNA) in Stratagene's Real Time PCR
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System (Agilent Technologies) using 3000p software v2.0.1 for data analysis.

Analysis of PCR products
PCR products were analyzed for the presence of specific DNA fragments by
running 20 µL of the sample on 1.5% agarose gels made in TAE buffer. The molecular
weight markers (MWM) used were 1 kb and 2 log DNA (New England BioLab Inc.
Ipswich, MA) according to the relative sizes of CAR, mCherry, and other junction
proteins used as controls. The electrophoresis apparatus was run for 30 min at 110 V.
DNA sizes in the PCR products were estimated by comparing the position of the bands of
interest to the closest band on the MWM.

MTT assay
CaLu-3 cells were seeded in a 96 well plate and treated with increasing
concentrations of either DMSO (24 h), chemical inhibitor PP2 (24 h), or
paraformaldehyde (15 min) then assayed for cell viability via [3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bromide] (MTT) assay).

A 4 mM MTT solution was

prepared by adding 16.57 mg of MTT (a yellow powder) to 10 ml of PBS then syringe
filtered under sterile conditions (a pale yellow solution). 30 µL of the 4 mM MTT
solution was added to cells still overlaid with 100ul of media without phenol red and
placed in the incubator for 4 h. Mitochondrial dehydrogenase enzymes of viable cells
cleave the tetrazolium rings of the pale yellow MTT and form dark blue formazan
crystals. The formazan crystals were solubilized by adding 100 µl of 0.08 N HCl in
isopropanol to each well and pipetting vigorously. Absorbance of converted dye was
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measured at a wavelength of 570 nm with background subtraction at 630 nm on a
microtiter plate reader. Each experiment was performed in 4-6 biological replicates.

Half-life protein extraction
In a pulse chase structured experimental design, MDCK stable cells	
   expressing	
  
CAREx7,	
   CAREx8,	
   or	
   mCherry	
   under	
   a	
   doxycycline	
   (Dox)	
   inducible	
   promoter were
seeded in plastic six-well plates at 4x104 cells per well and allowed to attach for a
minimum of 12 h. The cells were then induced with doxycycline [100 ng/ml] for 24 h to
express the protein of interest. The cells were then washed with PBS+/+ and then
replaced with FBS tetracycline negative (FBS tet (-)) media, and for some experiments,
the media also contained the protein synthesis inhibitor cycloheximide (CHX) (30 µg/ml)
as indicated in the text. Immediately after the media was replaced, the harvest time
points began respectively labeled as the time harvested post doxycycline removal (0, 4, 6,
8, 10, 12, and 24 h or as indicated in the text) where 0 h is immediately after doxycycline
removal and 24 h is 24 h after doxycycline removal. The lysates/protein levels were
analyzed via Western blotting. Experimental model shown in Figure 5. A similar
experimental design was used for CAR turnover at the apical surface and was examined
via cell surface biotinylation and Western blot or adenovirus infection via β-galactosidase
assay (Fig. 6).

Half-life quantitation analysis
Western blot band densities were quantified using ImageJ software, then
normalized to their respective actin bands. Using GraphPad Prism, half-life graphs were

25	
  

	
  

formatted by plotting the normalized values using a plateau followed by a one phase
exponential decay [37]. The plateau was determined by the GraphPad Prism software.
Protein half-lives were calculated using the following methods [37]:

	
  

𝑁(𝑡) = 𝑁! 𝑒 !!"
ln(𝑁) − ln(𝑁! ) = −𝑘𝑡   →    𝑇!! =
!

ln  (2)
𝑘

	
  
Equation 1. Determination of rate constant k, and
half-life.

Statistical analysis
Microsoft Excel and GraphPad Prism V5 (La Jolla, CA) were used to perform
statistical analyses. Significant differences were analyzed using one-way or two-way
ANOVA tests, followed by Tukey or Dunnett post hoc test to determine individual
differences between control and experimental conditions. Data are represented by Mean ±
SEM. Results were considered to be statistically significant if a p<0.05 was obtained.
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24h
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D.
Ex7
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Figure 5. Pulse chase model for identifying CAR and CAR half lives
using the doxycycline-inducible MDCK stable cell lines. A. MDCK cells
Ex7
Ex8
stably expressing Flag-tagged CAR , CAR or mCherry (a red fluorescent
protein; control) under a doxycycline promoter were seeded on a plastic 12-well
dish in FBS tet (-) media. The cells were permitted to settle and attach to the
plate for approximately 24 h. B. The cells were then induced (i.e. turned on)
with 100 ng/ml doxycycline in FBS tet (-) media for 24 h. C. After 24 h of
exposure to doxycycline, the doxycycline containing media was removed and
replaced with standard conditioned FBS tet (-) media (Aim: 3.2.4 and 3.2.5) or
FBS tet (-) media supplemented with 30 ng/ml cycloheximide (a protein
synthesis inhibitor) (Aim: 3.2.6). D. The cells were then lysed at increasing
time points: 0 h (immediately after Dox removal), 4 h, 8 h, 10 h, 12 h, or 24 h
hours post doxycycline removal. E. Western blot analysis of the protein lysates
was performed. The blots were then probed with rabbit anti-Flag antibody or
anti-actin to determine the amount of protein expression and rate of degradation
relative to a housekeeping protein.
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i.) Western blot
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Figure 6. Pulse chase model for identifying i.) apical CAR turnover; and ii.)
Ex7
Ex8
adenovirus transduction as CAR and CAR degrades, using doxycyclineinducible MDCK stable cell lines. A. MDCK cells stably expressing Flag-tagged
Ex7
Ex8
CAR , CAR
or mCherry (a red fluorescent protein; control) under a
doxycycline promoter were seeded on a plastic i.) 6-well or ii.) 24-well dish in FBS
tet (-) media. The cells were permitted to settle and attach to the plate for
approximately 24 h. B. The cells were then induced (i.e. turned on) with 100 ng/ml
doxycycline in FBS tet (-) media at increasing time points over the course of 24 h.
Each condition was permitted to express for 24 h in the presence of doxycycline.
C. After 24 h of exposure to doxycycline, the doxycycline containing media was
removed at increasing time points over the course of 24h and replaced with
standard conditioned FBS tet (-) media. D. At the last time point (T0:0 h) all the
cells were either i.) apically labeled with biotin on ice (as described in materials
and methods); or ii.) transduced with AdV-β-Gal (MOI 100) for 1 h. E. i.)
Isolated-biotinylated proteins were analyzed by Western blot (Aim 3.2.5); ii.) cells
were analyzed for β-Gal activity 24 h later via β-Galactosidase assay (Aim 3.2.8).
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Chapter 3. Coxsackievirus and adenovirus receptor half-life
3.1 Rationale
Protein turnover plays an important role in cellular processes. The half-life of a
protein will help to determine how stable and tightly regulated that protein is. Knowing
the turnover rate of a protein can help in determining exposure periods and working
concentrations of therapeutic treatments aimed at manipulating the levels of that
particular protein. Proteins with several isoforms may have different half-lives due to
differential regulation at many different levels such as gene expression, transcript
abundance and splicing, translation, post-translational modifications, protein-protein
interactions, and localization. It was hypothesized that CAREx8 will have a shorter halflife than CAREx7.

To test this hypothesis, stable cell lines expressing one of the

following: Flag-tagged CAREx7, CAREx8, or the red fluorescent protein (RFP) mCherry,
under the control of a doxycycline-inducible promoter (Fig. 4); were used in pulse chase
structured experiments to determine the half-lives of each protein (Fig. 5).

3.2 Results
3.2.1 Doxycycline is not toxic to the MDCK stable cells.
Doxycycline is an antibiotic that may have toxic effects on mammalian cells
in high doses.

Since cell viability and the ability to maintain junction integrity is

important for most of my experiments, I first tested if doxycycline showed toxicity to the
MDCK stable cells.

The cells were treated with increasing concentrations of
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doxycycline for 24 h or formaldehyde (positive control) for 15 min to determine
chemical toxicity. As the concentration of doxycycline increased there was no change in
cell viability compared with the no treatment condition, whereas within 15 min the cells
showed noticeable decreases in viability when exposed to increasing concentrations of
formaldehyde (Fig. 7). These data confirm that doxycycline is not toxic to the cells
within the working concentrations of my experiments.

3.2.2 MDCK stable CAREx8 cells produces detectible Flag-tagged CAREx8 after 4 h
of exposure to doxycycline, however the cells revert back to their parental state once
the doxycycline is removed.
Knowing that the doxycycline is not toxic to the MDCK stable cells, we then
asked how long it takes to detect CAREx8 expression after exposure to doxycycline. To
answer this question, MDCK CAREx8 stable cells were induced with 100 ng/ml
doxycycline and were permitted to express CAREx8 (Fig. 8).

The cells were then

harvested at increasing time intervals. The lysates were analyzed via Western blot using
an antibody specific for the flag sequence. CAREx8 could be observed as early as 4 h
after induction (Fig. 8). Following in suit the amount of CAREx8 protein increased as
doxycycline exposure time was increased. These data show that CAREx8 expression
vector is sensitive to doxycycline induction and protein synthesis is detectible at 4 h.
Just as the induction with doxycycline of the MDCK CAREx8 stable cells increased
CAREx8 expression over time, the removal of doxycycline reverts the cells back to a
parental state in which no Flag-tagged CAREx8 can be detected. This was tested by
inducing MDCK CAREx8 stable cells with 100 ng/ml doxycycline for 24h (Fig. 8.). The
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CAREx8
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*
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**

0.2

**

0.0
No
Dox
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Figure 7. Experimental concentrations of doxycycline does not cause
cytotoxicity. MDCK stable cells were seeded in a 96-well plate and incubated
either with no doxycycline (negative control), increasing concentrations of
doxycycline [100, 200, 1000 ng/ml] for 24 h (experimental), or with
formaldehyde [0.1*, 1*, 2* %] for 15 minutes (positive control), at 37°C. Cell
viability was assessed for four wells of cells per conditions by MTT assay. Error
bars indicate standard error of the mean (SEM). (* = P < 0.05; One-Way
ANOVA; Dunnett’s Post Hoc Test).
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Figure 8. Induction of MDCK stable CAR cells produce detectible
Ex8
levels of Flag-tagged CAR after 4 h of exposure to doxycycline, but
revert back to parental state once doxycycline is removed. MDCK
Ex8
cells stably expressing Flag-tagged CAR
under a doxycyclineinducible promoter were seeded on a plastic 24-well dish in FBS tet (-)
media. Cells were induced with doxycycline at ~80% confluence. A
portion of the cells were then lysed at either 1, 4, 8*, 12*, 24* h post
doxycycline induction. The remaining potion of the cells were induced
with doxycycline for 24 h. The doxycycline was then removed and the
cells were lysed at either 0*, 4*, 8*, 10, 12, and 24 h post doxycycline
removal. Western blot analysis of the protein lysates was performed.
The blots were then probed with rabbit anti-Flag antibody, followed by
HRP-labeled anti-rabbit antibody, to determine the earliest time point in
Ex8
which Flag-CAR could be detected, and if the expression was in fact
time dependent and transient. (* = P < 0.05; One-Way ANOVA; Tukey’s
Post Hoc Test).
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doxycycline media was removed and replaced with standard FBS tet (-) culture media.
The cells were harvested at increasing time points over the course of 24 h. The lysates
were then analyzed via Western blot. The results show that the induced CAREx8 protein
degraded in a time dependent fashion where no CAREx8 could be detected after 24 h, thus
reverting the stable cells back to their parental state. This again confirms that the CAREx8
stable expression vector is sensitive to the presence of doxycycline. Also, it hinted at the
rate of CAREx8 protein decay. This led to my next hypothesis that these MDCK stable
cell lines could be used to determine CAREx7 and CAREx8 half-lives.

3.2.3 Experimental rational, structure, and design.
As shown previously, the CAREx8 expression vector is highly sensitive to
doxycycline exposure and shows no signs of the vector being leaky. I proposed that the
MDCK stable cells lines are ideal model cell lines to study CAR protein turnover in.
Optimal conditions and time frames were determined for said experiments and are
modeled in (Fig. 5).

3.2.4 Removal of doxycycline shows a time dependent degradation of induced
proteins.
It was hypothesized that the MDCK stable cells could be used to monitor
protein degradation over time. Using a pulse chase structured experimental design, the
stable cells were induced with 100 ng/ml doxycycline for 24 h to allow for protein
expression. The doxycycline was then removed and replaced with standard tet (-) culture
media. The cells were then harvested at increasing time intervals; the lysates were
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analyzed via Western blot. What was observed was that both CAREx7 and CAREx8
showed similar patterns of time dependent degradation over the course of 24 h.

3.2.4.1 CAREx8 degrades rapidly after doxycycline removal producing a short halflife.
CAREx8 serves as the low abundance isoform of CAR. Here we show that
overexpressed CAREx8 degrades rapidly and is undetectable by 24 h once expression has
stopped by removing doxycycline (Fig. 9). However when viewing the Western blot, the
CAREx8 protein appears to maintain a stable concentration until 8 h after doxycycline
removal. After 8 h hours the protein concentration decreases rapidly declining by half by
10 h after dox removal. CAREx8 decreases again by another half from 10 h to 12 h and is
undetectable by 24 h. From these data, the Western blot bands were quantified and
normalized so that the half-life of CAREx8 could be calculated. From these results it was
determined that the half-life of CAREx8 is short, residing at 2 h. The data show a plateau
followed by one phase decay. The cause for the stagnant plateau could be caused by
many different factors such as the protein being more stable at higher concentrations,
residual mRNA from the induced vector thus leading to continued protein synthesis,
residual dox inducing the promoter, or the protein may be in complex with other proteins
which might stabilize it, or the half-life rate is contingent on the concentration of protein
which would produce a varying half-life.
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Figure 9. CAR
degrades rapidly after doxycycline removal. A. MDCK cells
Ex8
stably expressing Flag-tagged CAR under a doxycycline promoter were seeded in
a plastic 12-well dish in FBS tet (-) media. Cells were induced with 100 ng/ml
doxycycline for 24 h. The doxycycline containing media was then removed and
replaced with standard FBS tet (-) culture media. The cells were lysed at either 0 h
(immediately), 4 h, 6 h, 8 h, 10 h, 12 h, and 24 h hours post doxycycline removal.
Western blot analysis of the protein lysates was performed. Representative Western
Ex8
blots for CAR (anti-Flag) and actin (loading control). B. Western blot bands were
Ex8
quantified using ImageJ software. CAR
bands were normalized to their
corresponding actin bands. These values were plotted in GraphPad Prism using a
plateau followed by a one-phase exponential decay from which the half-life value
was calculated. Error bars represent SEM. (* = P < 0.05; One-Way ANOVA; Tukey’s
Post Hoc Test).
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3.2.4.2 CAREx7 degrades after doxycycline removal producing a short half-life.
CAREx7 is the high abundance isoform of CAR.

Here we show that

overexpressed CAREx7 degrades rapidly and is undetectable by 24 h once expression has
stopped by removal of doxycycline (Fig. 10). However when viewing the Western blot,
the CAREx7 protein appears to maintain a stable concentration until 4 h after doxycycline
removal. After 4 h hours the protein concentration decreases steadily declining by half
by 10 h after dox removal. CAREx7 decreases again by another half from 10 h to 16 h and
is undetectable by 24 h. From these data, the Western blot bands were quantified and
normalized so that the half-life of CAREx7 could be calculated. From these results it was
determined that the half-life of CAREx7 is relatively short, residing at 5.1 h. The data
show a plateau followed by two phase decay. As with CAREx8, the cause for the stagnant
plateau could be caused by many different factors such as the protein being more stable at
higher concentrations, residual mRNA from the induced vector thus leading to continued
protein synthesis, residual dox inducing the promoter, or the protein may be in complex
with other proteins which might stabilize it, or the half-life rate is contingent on the
concentration of protein which would produce a varying half-life.

3.2.4.3 MDCK mCherry stable cells were used as a control to analyze “leaky
expression” and Flag-antibody specificity.
MDCK stable mCherry cells were used as a control to first test if the Flag-tag
antibody has any nonspecific binding within MDCK cell lysates, as well as to test the
efficacy of the promoter and the potency of the doxycycline. Here I show that the Flag
antibody used produces no non-specific bands upon Western blot of lysates of stable cells
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Figure 10. CAR
degrades at a slower rate than CAR
after doxycycline
Ex7
removal. A. MDCK Cells stably expressing Flag-tagged CAR under a doxycyclineinducible promoter were seeded in a plastic 12-well dish in FBS tet (-) media. Cells
were induced with 100 ng/ml doxycycline for 24 h. The doxycycline containing media
was then removed and replaced with standard FBS tet (-) culture media. The cells were
lysed at either 0 h (immediately), 4 h, 6 h, 8 h, 10 h, 12 h, and 24 h hours post
doxycycline removal. Western blot analysis of the protein lysates was performed. The
blots were then probed with rabbit anti-Flag antibody to determine the rate at which
Ex7
Ex7
Flag-CAR
degraded. Representative Western blots for CAR and actin (loading
control) are shown. B. Western blot bands were quantified using ImageJ software.
Ex7
CAR bands were normalized to their corresponding actin bands. These values were
plotted in GraphPad Prism using a plateau followed by a one-phase exponential decay
in which the half-life value was calculated. Error bars represent SEM. (* = P < 0.05;
One-Way ANOVA; Tukey’s Post Hoc Test).
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(Fig. 11). I also wanted to test if mCherry protein remains stable within the cell once the
doxycycline is removed. Fluorescence images suggest that there is some red cells
remaining 24 h after doxycycline is removed. Although half-life was not calculated, the
length of detectable fluorescence suggests a half-life longer than CAREx8 or CAREx7.

3.2.5 CAREx8 degrades rapidly at the apical surface of polarized epithelia after
doxycycline removal producing a short half-life.
As the primary adenovirus receptor, CAREx8 at the apical surface is arguably
of greatest concern to health. Above I show that overexpressed CAREx8 degrades rapidly
with a half-life of 2 h (Fig. 9). However, since CAREx8 localizes apically in polarized
epithelium, I then asked what is the rate of CAREx8 turnover at the apical surface. I
hypothesized that CAREx8 will maintain an even shorter half-life than total CAREx8 when
localized at the apical surface. To test this hypothesis, I used polarized MDCK CAREx8
stable cells and induced them with 100 ng/ml doxycycline at increasing times over the
course of 24 h, then let each condition express for 24 h. The doxycycline was then
removed for increasing time points over the course of 24 h and replaced with standard tet
(-) culture media. Once the last time point had been met, surface biotinylation was
performed and the biotinylated proteins were isolated with streptavidin beads and
analyzed via Western blot. When viewing the Western blot, the CAREx8 protein appears
to slightly stable for the initial 4 h after doxycycline removal but then decreases to
undetectable over 24 h (Fig. 12). At 8 h hours post doxycycline removal CAREx8 protein
appears to have decreased to nearly 25% of its original concentration. From these data,
the Western blot bands were quantified and normalized so that the half-life of CAREx8
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Figure 11. MDCK mCherry stable cells do not show “leaky expression” and
demonstrate Flag-antibody specificity. A. MDCK Cells stably expressing mCherry
under a doxycycline-inducible promoter were seeded in a plastic 12-well dish in FBS
tet (-) media. Cells were induced with 100 ng/ml doxycycline for 24 h. The
doxycycline containing media was then removed and replaced with standard FBS tet
(-) culture media. The cells were imaged and then lysed at either 0 h (immediately), 4
h, 6 h, 8 h, 10 h, 12 h, and 24 h hours post doxycycline removal. Western blot
analysis of the protein lysates was performed. The blots were then probed with rabbit
anti-Flag antibody to test specificity of the antibody. Representative blots for Flagtagged proteins and actin (loading control) are shown B. Fluorescent images of
mCherry (4X lens on a Nikon fluorescence microscope) over the course of 28 h post
Dox removal shows that mCherry exhibits time dependent decay. ((Fluorescent
images 0*,4*,8* h (* = P < 0.05; One-Way ANOVA; Tukey’s Post Hoc Test)).
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Figure 12. CAR
degrades rapidly at the apical surface of polarized
Ex8
epithelia. A. MDCK Cells stably expressing CAR
under a doxycyclineinducible promoter were seeded in a plastic 12-well dish in FBS tet (-) media. Over
a course of 24 h the cells were induced at different time points with 100 ng/ml
doxycycline. Once each condition had been induced for 24 h, the doxycyclinecontaining media was then removed at increasing time points over a course of 24 h
and replaced with standard FBS tet (-) culture media. At the last time point the
cells were then chilled on ice where surface biotinylation was then performed.
Ex8
Cells were lysed and lysates (actin) or isolated-biotinylated proteins (CAR ; Flag
Ab) were then analyzed via Western blot. B. Western blot bands were quantified
Ex7
using ImageJ software. CAR
bands were normalized to their corresponding
actin bands. These values were plotted in GraphPad Prism using a plateau
followed by a one-phase exponential decay from which the half-life value was
calculated. (* = P < 0.05; One-Way ANOVA; Tukey’s Post Hoc Test).
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could be calculated. From these results it was determined that the half-life of CAREx8 is
short, residing at 1.8 h.

3.2.6 CAR half-life is unchanged upon treatment with cycloheximide.
From the previous data, it can be seen that the half-life curves contained a
plateau followed by a one-phase decay. The plateau principle is applied to biological
systems when a drug is being administered continuously or at steady intervals which can
affect cellular functions. It also applies to endogenous cases such as protein abundance
in response to a hormone. In our case, our cells were exposed to a continuous amount of
doxycycline for a 24 h time frame. The doxycycline was removed, and protein levels
were assessed at increasing time points.
expression of mRNA transcripts.

However, the doxycycline induces the

Once the doxycycline is removed, the mRNA

transcripts that were expressed are still able to be translated until they too are degraded.
Thus, we hypothesized that the plateau effect was caused by residual mRNA being
translated even after doxycycline was removal. To test this hypothesis, we used the same
experimental protocol as demonstrated in (Fig. 5), however, once the doxycycline was
removed, the cells were replenished with standard tet (-) culture media supplemented
with cycloheximide (CHX), a protein synthesis inhibitor, to inhibit translation of nascent
proteins. If the plateau was in fact due to the translation of residual mRNA, then the
cycloheximide should block this process, and the new curves should yield more accurate
protein half-life values.
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3.2.6.1 CAREx8 half-life is unchanged upon treatment with cycloheximide.
In theory, if the CAREx8 half-life observed in (Fig. 9) is accurate, then the
addition of cycloheximide will only serve to eliminate the plateau; however the half-life
should remain relatively the same. To test this hypothesis, the MDCK stable CAREx8 cells
were treated with doxycycline for 24h. The doxycycline was then removed and replaced
with standard tet (-) culture media containing cycloheximide, a protein synthesis inhibitor
and lysed at increasing time points. As hypothesized, the addition of cycloheximide did
in fact substantially reduce the large plateau initially seen in (Fig. 9) to nearly a nonexistent plateau (Fig. 13). Again, corroborating with the hypothesis, the half-life of
CAREx8 remained the same at 2.0 h.

3.2.6.2 CAREx7 half-life is increased upon treatment with cycloheximide.
As aforementioned, in theory, if the CAREx7 half-life observed in (Fig. 10) is
accurate, then the addition of cycloheximide will only serve to eliminate the plateau,
however the half-life should remain relatively the same. To test if CAREx7 half-life is
changed by the addition of cycloheximide, the MDCK stable CAREx7 cells were treated
with doxycycline for 24 h.

The doxycycline was then removed and replaced with

standard tet (-) culture media containing cycloheximide, a protein synthesis inhibitor and
lysed at increasing time points. Here we show that the estimated half-life for CAREx7 is
5.3 h (Fig. 14) which is consistent with the above reported half-life of 5.1 h.
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Figure 13. Cycloheximide effectively reduces the plateau phase during
Ex8
CAR
degradation, but still produces the same half-life. A. MDCK Cells
Ex8
stably expressing Flag-tagged CAR
under a doxycycline-inducible promoter
were seeded in a plastic 12-well dish in FBS tet (-) media. Cells were induced
with 100 ng/ml doxycycline for 24 h. The doxycycline containing media was then
removed and replaced with standard FBS tet (-) culture media supplemented with
30 µg/ml cycloheximide (a protein synthesis inhibitor). The cells were lysed at
either 0 h (immediately), 4 h, 6 h, 8 h, and 10 h post doxycycline removal.
Western blot analysis of the protein lysates was performed. The blots were then
Ex8
probed with rabbit anti-Flag antibody to determine the rate at which Flag-CAR
Ex8
degraded. Representative CAR and actin (loading control) Western blots are
Ex8
shown. B. Western blot bands were quantified using ImageJ software. CAR
bands were normalized to their corresponding actin bands. These values were
plotted in GraphPad Prism using a plateau followed by a one-phase exponential
decay from which the half-life value was calculated. (* = P < 0.05; One-Way
ANOVA; Tukey’s Post Hoc Test).
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Figure 14. Cycloheximide reduced the plateau phase of CAR degradation and
Ex7
does not significantly alter CAR half-life. A. MDCK Cells stably expressing
Ex7
Flag-tagged CAR under a doxycycline-inducible promoter were seeded in a plastic
12-well dish in FBS tet (-) media. Cells were induced with 100 ng/ml doxycycline
for 24 h. The doxycycline containing media was then removed and replaced with
standard FBS tet (-) culture media supplemented with 30 µg/ml cycloheximide (a
protein synthesis inhibitor). The cells were lysed at either 0 h (immediately), 4 h, 6
h, 8 h, and 10 h post doxycycline removal. Western blot analysis of the protein
lysates was performed. The blots were then probed with rabbit anti-Flag antibody to
Ex7
Ex7
determine the rate at which Flag-CAR degraded. Representative CAR and actin
(loading control) Western blots are shown. B. Western blot bands were quantified
Ex7
using ImageJ software. CAR bands were normalized to their corresponding actin
bands. These values were plotted in GraphPad Prism using a plateau followed by a
one-phase exponential decay from which the half-life value was calculated. (* = P <
0.05; One-Way ANOVA; Tukey’s Post Hoc Test).
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3.2.7 Endogenous CAREx8 and total-CAR half-lives yield a steady rate of decay in
CaLu-3 cells.
Our lab is interested in how CAR is being regulated in polarized human
airway epithelial. However, in the previous studies, CAR half-life was being determined
using an inducible MDCK stable cell line, thus all the CAREx7 and CAREx8 were both
over expressed and Flag-tagged at the N-terminus. Four major limitations are presented
in these experiments i.) these cell lines are canine kidney cells although the CAR gene
within the integrated inducible vector being expressed is human and thus may not be
recognized or degraded at the same rate as endogenous CAR; ii.) over expression of these
proteins may overwhelm the cells regulation machinery; iii.) residual mRNA from
overexpression allows for nascent protein translation once doxycycline induction has
stopped, possibly altering the time frame of degradation; and iv.) the Flag-tag on the
proteins may disturb or alter the rate of protein degradation. To address these limitations,
CAR half-life was observed in CaLu-3 cells, a highly-studied human lung cell line able to
polarize into an epithelium. This was done by treating CaLu-3 cells with cycloheximide
for different lengths of time, then lysing the cells and determining the concentration of
CAREx8 and total-CAR at increasing time points (Fig. 15). Interestingly, the calculated
half-lives of both CAREx8 and total CAR were roughly the same as initial experiments
performed in the MDCK stable cell lines, with half-lives at 2.4h (CAREx8) and 4.5h
(total-CAR; a combination of both CAREx7 and CAREx8) when plotted with a plateau
followed by a one phase decay.
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Figure 15. Endogenous CAR and total-CAR half-lives are relatively short in
CaLu-3 cells. A. CaLu-3 cells were treated with 30 µg/ml cycloheximide (a protein
synthesis inhibitor). The cells were lysed at either 0 h (immediately), 1 h, 2 h, 4 h, 8
h, and 24 h post cycloheximide addition. Western blot analysis of the protein lysates
Ex8
was performed. The Western blots were then probed with rabbit-5678 (CAR
specific antibody) or rabbit-1605 (Total-CAR antibody), and anti-actin (loading
Ex8
control). B. Western blot bands were quantified using ImageJ software. CAR and
total-CAR bands were normalized to their corresponding actin bands. These values
were plotted in GraphPad Prism using a plateau followed by a one-phase exponential
decay from which the half-life value was calculated. (* = P < 0.05; One-Way
ANOVA; Tukey’s Post Hoc Test).
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3.2.8 Adenovirus transduction decreases as CAREx8 degrades but remains
unaffected with CAREx7 degradation.
Induction of MDCK CAREx7 and CAREx8 stable cells with doxycycline
increases the expression of either CAREx7 or CAREx8 (Fig. 4).

Correspondingly,

adenovirus infection of these polarized cell lines increases most when CAREx8, the apical
surface isoform of CAR, is overexpressed and not upon overexpression of CAREx7, the
isoform sequestered on the basolateral surface of the polarized cells (data not shown) [9].
The removal of doxycycline reverts the cells back to a parental state in which no Flagtagged CAR can be detected (Fig. 9A; Fig. 10A). It was then asked if the degradation of
these proteins affects adenoviral infection. This was tested by inducing the polarized
MDCK CAREx7 or CAREx8 stable cells with 100 ng/ml doxycycline for 24 h. The
doxycycline media was removed at increasing time intervals (0 h – 24 h) and replaced
with standard culture media.

Once each time point had been met, the cells were

transduced with recombinant adenovirus carrying the β-galactosidase reporter gene (MOI
100) for 1 h. β-galactosidase activity was analyzed 24 h later. The results showed that as
the induced CAREx8 protein degraded there was a direct correlation with a decrease in βgalactosidase activity (Fig. 16A; p<0.05). Conversely as the induced CAREx7 protein
degraded, there was little to no change in β-galactosidase activity (Fig. 16B). These data
further confirm that CAREx8 not only localizes at the apical surface of polarized epithelia
but also acts as the primary receptor for adenoviruses.
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Figure 16. Adenovirus transduction decreases as CAR degrades but remains
Ex7
unaffected with CAR
degradation. MDCK Cells stably expressing FlagEx8;
Ex7
tagged A. CAR
or B. CAR
under a doxycycline-inducible promoter were
seeded in a plastic 24-well dish in FBS tet (-) media. Over a course of 24 h the cells
were induced at different time points with 100 ng/ml doxycycline. Once each
condition had been induced for 24 h, the doxycycline containing media was then
removed at increasing time points over a course of 24 h and replaced with standard
FBS tet (-) culture media. At the last time point the cells were then transduced with
AdV-β-Gal (MOI 100) for 1 h. β-Gal activity was assessed from four wells of cells
per condition 24 h later by β-galactosidase assay. Error bars indicate standard error
of the mean (SEM). (A.* = P < 0.05; One-Way ANOVA; Tukey’s Post Hoc Test).
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3.3 Conclusion
Due to the nature in which the proteins degraded, it was hypothesized that the
half-life of both CAREx7 and CAREx8 could be calculated from the Western blots. First,
ImageJ software was used to quantify the band density of the proteins of interest (CAREx7
or CAREx8). The corresponding band density for actin (a house keeping gene) was also
quantified.

The band values of the proteins of interest (CAREx7 or CAREx8) were

normalized to their corresponding actin band values. Next, these values were plotted in
Prism, GraphPad on either a plateau followed by a one-phase exponential decay plot, or a
standard first ordered one phase exponential decay plot

where program software

generated standard error of the mean (SEM), an R2 value, and the relative half-lives by
way of (eq. 1) for the proteins of interest. From these studies the half-lives of CAREx7,
CAREx8, apical turnover of CAREx8, and total-CAR were calculated (Table 2).
Based on the above, data it is clear that the MDCK stable cell lines were
appropriate models for studying CAREx7 and CAREx8 protein expression and degradation.
We also saw that it takes approximately 4h for the induced protein to be detected by
Western blot when using 100 ng/ml doxycycline. Next we showed that once doxycycline
is removed, cells revert back to a parental state, as the induced proteins are degraded in a
short time frame. From these data, it was hypothesized that the estimated half-lives for
CAREx7 and CAREx8 could be calculated. I further confirmed this hypothesis by showing
that CAREx7 has an estimated half-life of ~5.1 h while CAREx8 has an estimated half-life
of ~2 h. The apical turnover rate of CAREx8 is slightly faster than the total half-life of
CAREx8 at ~1.8 h using a plateau followed by a one phase decay. To address the
presence of the plateau seen in all of the Western blots and half-life graphs, I
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Table 2. Half-life of CAR isoforms.
Cell Line

CAR Isoform

Cycloheximide

Half-life (h)

MDCK CAREx8
Stable

CAREx8

-

2.0 ± 1.4

MDCK CAREx7
Stable

CAREx7

-

5.1 ± 0.6

MDCK CAREx8
Stable

Apical-CAREx8

-

1.8 ± 1.9

MDCK CAREx8
Stable

CAREx8

+

2.0 ± 1.5

MDCK CAREx7
Stable

CAREx7

+

5.3 ± 1.5

CaLu-3

CAREx8

+

2.4 ± 0.05

CaLu-3

Total-CAR

+

4.5 ± 0.02

50	
  

	
  

hypothesized that the plateau was caused by residual mRNA from the induced vector
once the doxycycline was removed. To test this, the same experiments were performed
in the presence of cycloheximide (a protein synthesis inhibitor) in order to prevent further
translation of existing mRNA.

Interestingly enough, the data obtained showed a

substantial reduction in the plateau time but yielded nearly the same half-life values as
the initial experiments with 2 h and 5.3 h for CAREx8 and CAREx7 respectively.
We then asked if endogenous CAREx8 in CaLu-3 cells shows the same trend in
degradation and maintains a similar half-life as calculated earlier in the MDCK stable
cells.

This was addressed by inhibiting protein synthesis in CaLu-3 cells with

cycloheximide then lysing the cells at increasing time points. Here we show that
endogenous CAREx8 decays at a slightly slower rate with a half-life of 2.4 h as compared
to the over expressed CAREx8 in the MDCK stable cells. Total CAR had a slightly shorter
half-life of 4.8 h that CAREx7 alone. This is possibly due to the presence of both isoforms
within the Western blot bands.
Lastly, to further confirm the ability for CAREx8 to act as the primary receptor
for adenoviruses in polarized epithelia, we show that as CAREx8 degraded in the MDCK
cells, there was a corresponding decrease in adenovirus transduction. However this same
trend was not seen with the MDCK cells overexpressing CAREx7. This shows that the
apical isoform of CAR, CAREx8, is responsible for initiating adenovirus infection from
the apical surface, while the basolateral isoform of CAR, CAREx7, is sequestered beneath
the tight junctions and is inaccessible for adenovirus transduction.
Protein half-lives differ from protein to protein. In mammalian cells the
global median protein half-life is ~46 h [38]. Localization of a protein within a polarized
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epithelium may play a significant role in a proteins half-life. Apical proteins have been
shown to have half –lives ranging from ~1h to ~24h and global analysis conferred that
plasma membrane proteins can have half-lives <100h or shorter half-lives >4h [39-42].
Protein degradation is usually a first order reaction, thus the half-lives were analyzed
using a plateau followed by a one-phase exponential decay [33, 43].
The limitation within the experimental designs lay with the conditional parameter
such as the use of cycloheximide. In that, cycloheximide does not inhibit 100% of protein
synthesis, but rather it only blocks 70-80% of protein synthesis, and takes a minimum of
15 min exposure to be effective therefore, there still may be nascent protein translation
and thus the calculated values for the varying isoforms of CAR may not be true
representations of protein decay. In the future, these experiments should be repeated with
more time points at shorter intervals, and either a higher concentration of cycloheximide,
or a different protein synthesis inhibitor such as emetine, or by radioactively labeling
newly synthesized proteins [44, 45].
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Chapter 4. Src-family kinases role in the expression of the coxsackievirus and
adenovirus receptor and adenovirus infection.
4.1 Rationale
Since CAR is tightly regulated, as shown by the relatively short half-life (Table
2.), I then asked what protein interactions are involved in the regulation of CAR. Here I
focused my studies on the role of the Src-family kinases in the expression of CAR and
adenovirus infection.
Cell signaling plays an important role in viral infection. After a virus attaches to
its primary receptor, a signaling cascade is set in motion in order for the virus to be
internalized by the cell. Further signaling is required to successfully traffic the virus to its
site of replication. Kinases play a large part in these signaling cascades. Previous studies
have shown that Src-family kinase inhibition decreased adenoviral infection in airway
epithelia [21]. The reduced infection was attributed to the mislocalization of integrins to
the basolateral surface of the polarized epithelium. However, CAR has several putative
phosphorylation sites at its C-terminus, which are potential locations for phosphorylation
by Src-family kinases. These potential interactions led to the hypothesis that Src-family
kinases alter adenoviral entry by regulating the expression of CAREx8. To test this
hypothesis, CaLu-3 cells were treated with various Src-family kinase inhibitors and
analyzed for viral entry and transduction, as well as CAREx8 expression.
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4.2 Results
4.2.1 Optimizing CaLu-3 cell culture and experimental conditions.
CaLu-3 cells are a polarizing epithelial lung cell line. As mentioned earlier,
polarized epithelia are highly resistant to viral infection unless there is abundant CAREx8
at the apical surface. CaLu-3 cells are able to form a well differentiated polarized
monolayer, however, they also exhibit odd growth patterns in that they can grow in dense
clumps, or, once polarized, they begin to grow on top of each other. If the cells are
seeded too low, they tend to not grow, but if seeded too high, they grow into a multilayer
cell sheet.

Initially when performing experiments, the data were not reproducible

because the cells would not grow the same every time. In order to optimize experimental
conditions with CaLu-3 cells, a series of experiments were performed to determine
appropriate cell seeding density, and efficient growth period for the cells so that
experimental conditions would be the same throughout the studies so that results would
be consistent and reproducible.

4.2.1.1 CaLu-3 cell seeding densities.
First, the cell seeding density of the CaLu-3 cells was addressed.

Standard

protocol suggests that CaLu-3 cells should be seeded at 2.5x105 in order to obtain a ~80%
confluence by the next day. However, it may take longer for cells to completely polarize
and form proper tight junctions. Also, most of the experiments performed require a
longer time frame for different treatment variables and viral infection. To examine the
most relevant cell seeding density, CaLu-3 cells were seeded on a 24 well dish at
increasing densities (1, 1.5, 2, 2.5 (x105)) of cells per well. The cells were then allowed
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Figure 17. CaLu-3 optimal cell seeding density. CaLu-3 cells were seeded at
increasing cell densities on a 24-well plate. The cells were allowed to adhere and
grow for 48 h post seeding. Each condition was imaged at either A. the edge of
the well; or B. the center of the well to determine relative confluence (10X lens on
a Nikon fluorescence microscope using bright field microscopy).
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to adhere and grow for 48 h and then observed for relative densities under 10 x bright
field microscopy (Fig. 17). From the images, it can be seen that when seeded at 1x105,
the CaLu-3 cells grew in dense clumps, while at 2x105 and 2.5x105 grew very dense in
the center of the well. However, when seeded at 1.5x105, the cells appeared healthier at
the center of the well, and cell borders were visible, with no over growth or growing on
top of each other. From these data, to optimal seeding density was determined to be
1.5x105 cells per well.

4.2.1.2 CaLu-3 cells take several days to polarize.
Next, I examined CaLu-3 growth period in order to determine the time needed to
establish a polarized monolayer. This was done by seeding CaLu-3 cells at 1.5x105 cells
per well on a 24 well dish, as determined was optimal in the previous study, and allowed
to grow for increasing time frames (24 h, 48 h, 72 h, 96 h). Then using AdV-GFP as a
surrogate marker for cell polarity, the cells were transduced with AdV-GFP for 1 h at an
MOI of 100 after the allotted growth period. GFP expression was analyzed 24 h later
using 10 x fluorescent microscopy (Fig. 18). Here we see that the cells were only
successfully infected at the periphery of the monolayers or at the cell islands. The cells
transduced at 24 h and 48 h post seeding show the most GFP expression, while 72 h, and
96 h show the least. However, the 96 h condition showed the most confluent monolayer.
Thus, allowing the cells to grow for 96 h before transduction would yield the best
polarized monolayer without allowing the cells to over grow.
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Figure 18. CaLu-3 optimal growth period to form a polarized monolayer.
5
CaLu-3 cells were seeded at 1.5x10 on a 24-well plate. The cells were then
transduced with AdV-GFP (MOI 100) either 24 h, 48 h, 72 h, or 96 h after seeding.
The cells were observed 24 h later for GFP expression (10X lens on a Nikon
fluorescence microscope). Each condition was imaged at either A. the edge of the
well; or B. the center of the well to determine relative confluence, polarity, and
AdV-GFP-mediated GFP fluorescence.
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4.2.1.3 Optimal conditions for experiments performed on CaLu-3 cells.
From the previous two studies, it was determined that the optimal cell seeding
density for CaLu-3 cells is 1.5x105 with a growth period of 96 h before adenovirus
transduction on a 24 well plate. These results show the ideal conditions for CaLu-3 cells
that yields a polarized monolayer of cells for conduction of experiments that produces
consistent and repeatable results (Fig. 19). However, even on larger tissue culture plates,
the CaLu-3 cells still pose the same difficulties in growth patterns. Thus, a similar set of
experiments were performed to determine optimal conditions for CaLu-3 cell seeding
density and growth period on 6 well plates. These conditions favored 2.5x105 cells per
well with 96 h growth period to obtain consistent results (data not shown).

4.2.2 Inhibiting Src-family kinases decreases adenovirus infection.
To confirm that inhibition of Src-family kinases decreases the adenoviral
infection of polarized epithelia, CaLu-3 cells, a model polarizing human lung cell line,
were treated with either DMSO (vehicle control) or increasing doses of one of the
following small molecule inhibitors for Src-family kinases, PP1 or PP2, for 1h. The
treated cells were then infected with adenovirus carrying the β-galactosidase reporter
gene (MOI 100) for 1 h, then washed and replenished with standard culture media
containing the chemical inhibitor.

The cells were analyzed 24 h later via a β-

galactosidase assay. As expected, the CaLu-3 cells showed a remarkable dose dependent
resistance to adenovirus infection upon treatment with the chemical inhibitors (Fig. 20;
p<0.001). From these data, the working concentration of PP2 was determined to be 5
µM. This was because 5 µM PP2 showed a similar decrease in viral infection (65%) as
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Figure 19. CaLu-3 optimal seeding density and growth period to form a
5
polarized monolayer. CaLu-3 cells were seeded at 1.5x10 on a 24-well plate and
allowed to polarize for 96 h. The cells were then transduced with AdV-GFP (MOI
100) and imaged for GFP expression 24 h later (10X lens on a Nikon fluorescence
microscope). Each condition was imaged at either A. the center of the well; or B.
the edge of the well to determine relative confluence and polarity.
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Figure 20. Inhibiting Src-family kinases decreases adenoviral transduction.
CaLu-3 cells were treated with Src-family kinase inhibitor A. PP1; or B. PP2
(small molecule inhibitors specific for Src-family kinases) for 1 h then transduced
with AdV-β-Gal (MOI 100) for 1 h. Cells were washed and replenished with
standard growth media containing chemical inhibitor over night. β-galactosidase
assay was performed 24 h later after transduction. β-Gal activity was assessed for
four wells of cells per condition by β-galactosidase assay. Error bars indicate
standard error of the mean (SEM). (* = P < 0.05; One-Way ANOVA; Tukey’s Post
Hoc Test).
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10 µM PP2 (70%). The lower concentration ensures less toxicity to the cells, as well as
less chance for off-target effects. Additionally, 5 µM PP2 has been shown to be an
effective concentration able to decrease other viral infections, such as decreasing reovirus
infection by 70% [32]. PP1 was not used to test any further viral infection assays
because the lowest dose that yielded a significant decrease in adenoviral infection was
100 µM. Thus, PP1 showed less specificity and has a higher potential to be toxic to the
cells or cause off-target effects.

4.2.3 PP2 inhibits adenovirus infection at an early stage in infection.
Since inhibiting Src-family kinases resulted in a significant decrease in adenoviral
infection I asked at what time point after adenovirus binding does Src-family kinase
inhibition decreases viral infection. Based on the findings with reovirus, which shows an
effect at early stages of infection [32], I hypothesized that Src family kinases play a
crucial role in adenoviral trafficking at an early time point. To test this hypothesis,
CaLu-3 cells were treated with PP2 [5 µM], or DMSO as a control, for 1 h before (pre),
during, immediately after (post), or 1 h after (post) AdV-β-gal infection (Fig. 21;
p<0.05). Adenovirus transduction was analyzed 24 h later via a β-galactosidase assay.
Adenoviral transduction showed a marked decrease in the immediate post-treated
conditions. Whereas, the pre-treated and 1 h post treated cells showed a negligible
decrease in transduction. These data suggest that Src-family kinases play a crucial role in
viral trafficking immediately post viral internalization. It is predicted that inhibiting Srcfamily kinases at an early time point in viral infection results in decreased viral
trafficking to the nucleus and increased viral degradation.
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Figure 21. Inhibiting Src-family kinases with PP2 decreases adenoviral
transduction at an early point in viral entry. CaLu-3 cells treated with PP2 [5
µM] at different time points relative to adenovirus infection: either before, during,
or after transduction with AdV-β-Gal (MOI 100; 1 h). β-Gal activity was assessed
for four wells of cells per condition 24 h later by β-galactosidase assay. Error bars
indicate standard error of the mean (SEM). (* = P < 0.05; One-Way ANOVA;
Tukey’s Post Hoc Test).

62	
  

	
  

4.2.4 Inhibiting Src-family kinases with PP2 for extended time frames decreases
adenoviral genomes.
Initially, we showed that adenoviral transduction exhibited a dose dependent
decrease when treated with the Src-family kinase inhibitor PP2 (Fig. 20).

I then

investigated at what time does Src-family kinase inhibition with PP2 play a role in viral
infection. It was shown that PP2 acts at an early stage in viral infection, roughly within
the first hour post infection. However, viral infection decreased by only 30% (Fig. 21)
whereas in dose response assay, viral infection decreased by 65% (Fig. 20).

We then

hypothesized that extended Src-family kinase inhibition results in further decrease in
viral transduction. To test this hypothesis, CaLu-3 cells were treated with PP2 [5 µM] for
8 h or 24 h then transduced with recombinant adenovirus (MOI 100) for 1 h then
analyzed for viral genomes 24 h later (Fig. 22; p<0.0001). In congruence with the
hypothesis, inhibiting Src-family kinases for 8 h pre-adenovirus infection showed an 80%
decrease in viral genomes, while 24 h inhibition reduced viral genomes to nearly zero.
The significant decrease in viral genomes could be caused by several factors such as a
decrease in i.) viral receptor (i.e. CAR mRNA, protein, or localization); ii.) viral
trafficking to the nucleus; iii.) replication machinery; or iv.) off-site targets.

4.2.5 Inhibiting Src-family kinases has no noticeable effect on CAREx8 at early time
points.
To address the decrease seen in viral genomes with extended Src-family kinase
inhibition, we hypothesized that inhibiting Src-family kinases for an extended time
decreases CAREx8 abundance in epithelial cells. To test this hypothesis, CaLu-3 cells
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Figure 22. Inhibiting  Src-family  kinases  with  PP2  
Figure 22. Inhibiting
Src-family kinases with PP2 for extended time points
for   extended   time   points   decreases   adenoviral  
decreases adenoviral genomes. CaLu-3 cells were treated with PP2 [5 µM]
genomes.      CaLu-3   cells   were   treated   with   PP2   [5  
for 8 h or 24 h then transduced with recombinant adenovirus (MOI 100) for 1
μM]   for   8   h   or   24   h   then   transduced   with  
h. Then DNA isolated from total lysates was analyzed for viral genomes by
recombinant   adenovirus   (MOI   100)   for   1   h,   then  
qPCR 24 h later. Viral genomes were quantified for four wells of cells per
DNA   isolated   from   total   lysates   were   analyzed   for  
condition. Error bars indicate standard error of the mean (SEM). (* = P <
viral  genomes  24  h  later.  qPCR  was  performed  24  h  
0.0001; One-Way ANOVA; Tukey’s Post Hoc Test).
later.  Viral  genomes  were  quantified  for  four  wells  of  
cells   per   conditions   by   qPCR.      Error   bars   indicate  
standard  error  of  the  mean  (SEM);;  (p<0.0001).
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were treated with PP1 [0, 1, 10 µM] for 24 h or PP2 [5 µM] for increasing time points
then harvested and analyzed via Western blot (Fig. 23).

In congruence with my

hypothesis, CAREx8 expression did show a substantial decrease with extended exposure
to PP2 but showed no change within the early time points of treatment (Fig. 23B). Also,
increasing concentrations of PP1 exhibited no effect on CAREx8 expression (Fig. 23A).
Knowing that CAREx8 has a half-life of 2.4 h in CaLu-3 cells (Fig. 15), we predicted that
if inhibiting Src-family kinases had a direct role in CARex8 protein expression, then we
would expect to see a decrease in protein levels at the earlier time points. However, this
was not the case. Thus, inhibiting Src-family kinases could have an indirect role in
CAREx8 expression, or extended exposure to PP2 could have potential off target effects,
or exhibit a degree of cytotoxicity.

4.2.6 Src-family kinase inhibitor is not toxic to CaLu-3 cells.
To determine if PP2 is toxic to the cells, CaLu-3 cells were treated with
increasing concentrations of PP2 for 24 h or formaldehyde for 15 min (positive control).
Cell viability was determined using an MTT assay.

As the concentration of PP2

increased there was no change in cell viability compared with the no treatment condition,
whereas within 15 min the cells showed noticeable decreases in viability when exposed
to increasing concentrations of formaldehyde (Fig. 24).

These data confirm that PP2 is

not toxic to the cells within the working concentrations of my experiments, and further
confirms that the decrease seen in CAREx8 expression and adenoviral genomes with
extended exposure to PP2 is a result of indirect Src-family kinase regulation of CAREx8
or off-target effects of the chemical inhibitor.
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Figure 23. Inhibiting Src-family kinases does not change CAR expression at early
time points. A. CaLu-3 cells were treated with PP1 [1 and 10 µM] or DMSO for 24 h
Ex8
Ex8
then CAR expression was analyzed by Western blot. B. CAR band density relative
to actin. C. CaLu-3 cells were treated with PP2 [5 µM] or DMSO for increasing times
Ex8
Ex8
then CAR expression was analyzed by Western blot. D. CAR band density relative
to actin.

66	
  

	
  

0.25

Optical Density

0.2
0.15
0.1
0.05
0
(-) PP2

PP2

DMSO

Formaldehyde (-) Cells

Figure 24. Experimental concentrations of PP2 and DMSO do not cause
cytotoxicity. CaLu-3 cells were seeded in a 96-well plate and incubated either with no
PP2, negative control; PP2 [0.1, 1, 5, 10 µM] for 24 h, experimental; or with
formaldehyde [0.1, 1, 2 %]* for 15 minutes, positive control; at 37°C. Cell viability
was assessed for four wells of cells per condition by MTT assay. Error bars indicate
standard error of the mean (SEM). (* = P < 0.05; One-Way ANOVA; Dunnett’s Post
Hoc Test).
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4.2.7 Adenovirus activates c-Src kinase at early time points during infection.
Src-family kinases remain inactive within the cell by auto-phosphorylation at
tyrosine 527 (Y527) (Fig. 25) [46, 47]. However, in response to stimuli, Src-family
kinases are dephosphorylated at Y527 and become phosphorylated at tyrosine 416
(Y416) rendering the kinase active (Fig. 25)[46]. Inhibiting Src-family kinases inhibits
the kinases ability to be activated and thus leads to a significant decrease in adenoviral
infection. This suggests that active Src-family kinases are required for efficient
adenoviral infection.

I hypothesized that adenovirus infection activates Src-family

kinases in order to promote viral infection. To test this hypothesis, CaLu-3 cells were
serum starved then adsorbed with adenovirus at 4°C for 1 h. The cells were washed and
lysed at 0, 30, and 60 minutes after being placed back into the incubator at 37°C and 5%
CO2. Whole cell lysates were then analyzed via Western blot (Fig. 26). The results
showed that c-Src kinase is activated at an early time point during adenovirus infection
and decreases activity over the course of infection. This suggests that c-Src kinase plays
a role in infection by way of viral entry or trafficking.

4.2.8 Activating Src-family kinases does not alter adenovirus infection or CAREx8
expression.
Previously it was shown that inhibiting Src-family kinases decreases adenoviral
infection while adenovirus infection activates c-Src kinase at an early stage in infection.
This led me to hypothesize that increasing Src-family kinase activity would increase
adenoviral infection. To test this hypothesis, CaLu-3 cells were treated with DMSO or
increasing concentrations of Src-family kinase activator (SC-3052) for 1 h, then infected
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Figure 25. Model of Src-family kinases. A. Linear model of protein structure.
B. Phosphorylation dependent activation states of Src-family kinases.
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Figure 26. Adenovirus activates c-Src kinase. A. CaLu-3 cells were seeded on a 6well plate and grown to ~80% confluence. The cells were then chilled and treated with
DMSO or adsorbed with adenovirus (MOI 1000) at 4°C for 1 h. The cells were washed
then placed back at 37°C. The cells were then lysed at increasing time points, after
DMSO or viral adsorption (as indicated above), with lysis buffer containing protease
and phosphatase inhibitors. Lysates were then analyzed by Western blot. The blot was
probed with rabbit-Phospho c-Src-Y416 (an antibody specific for active c-Src) or actin
(a loading control). B. Phospho c-Src-Y416 band density relative to actin.
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with recombinant AdV-β-gal (MOI 100) for 1 h in the presence of the activator (Fig.
27A). The cells were then washed and replenished with standard growth media and
chemical activator, and analyzed for viral transduction 24 h later via a β-galactosidase
assay. The results show that as the concentration of Src activator increased, there was no
significant change in adenoviral transduction.
Although viral transduction did not change with Src-family kinase activation,
CAREx8 expression was still examined. CaLu-3 cells were treated with Src activator for
increasing time intervals then lysed and analyzed by Western blot. In correlation with the
β-galactosidase assay cells incubated with Src-family kinase activator showed no
noticeable changes in CAREx8 expression (Fig. 27B).

4.2.9 c-Src kinase is required for efficient adenovirus infection.
Since the Src family inhibitors used above may inhibit several proteins in the
family, HeLa cells expressing shRNA for either c-Src kinase or a Scrambled shRNA
were used to specifically examine the role of c-Src kinase in adenovirus infection, (Fig.
28).

shHeLa cells were seeded and with AdV-β-Gal (MOI 100) for 1 h, washed,

replenished with standard culture media and analyzed for β-gal activity 24 h later (Fig.
28C; p<0.001).

It was observed that the cells expressing shRNA for c-Src kinase

significantly decreased in viral transduction by 70%. To confirm that c-Src kinase was
knocked down, c-Src expression was analyzed via Western blot (Fig. 28A, B). HeLa
cells expressing shRNA for c-Src demonstrated a 50% reduction in c-Src kinase
expression as compared to the HeLa-shRNA-Scramble control, indicating successful
knockdown of c-Src Kinase.
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Figure 27. Activating Src-family kinases does not affect adenoviral transduction
Ex8
or CAR expression. A. CaLu-3 cells treated with Src activator [0, 0.1, 1, 10, 100
µM] for 1 h then transduced with AdV-β-Gal (MOI 100) for 1 h. Cells were washed
and replenished with standard growth media. The cells were analyzed 24 h post
infection for β-Gal activity for four wells of cells per condition by β-galactosidase
assay. Error bars indicate standard error of the mean (SEM). B. CaLu-3 cells were
Ex8
treated with Src activator [10 µM] or DMSO for increasing time points. CAR
expression was analyzed by Western blot. (* = P < 0.05; One-Way ANOVA; Tukey’s
Post Hoc Test).
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Figure 28. c-Src shRNA decreases total c-Src kinase protein expression and
Ex8
adenoviral transduction but has no affect on CAR
expression. A. HeLa cells
expressing either shRNA for c-Src or a scrambled sequence (control) were analyzed for cSrc expression (Anti-Total c-Src) via Western blot. B. Quantitation of the c-Src bands
relative to actin. C. HeLa cells expressing either shRNA for c-Src or scramble were
transduced with AdV-β-Gal (MOI 100) for 1 h. β-Gal activity was analyzed 24 h later for
four wells of cells per condition by β-galactosidase assay. Error bars indicate standard
error of the mean (SEM). D. HeLa cells expressing either shRNA for c-Src or scramble
Ex8
Ex8
were analyzed for CAR (Anti-CAR -5678) or actin expression (loading control) via
Western blot. (* = P < 0.0001; One-Way ANOVA; Tukey’s Post Hoc Test).
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4.2.10 Knock down of c-Src kinase does not alter CAREx8 expression.
HeLa cells expressing shRNA for either c-Src or Scrambled shRNA were
analyzed for CAREx8 expression via Western blot (Fig. 28D). CAREx8 abundance did not
change with either shRNA vector, indicating that c-Src kinase does not play a role in
CAREx8 expression.

4.2.11 Broad inhibition of tyrosine protein kinases yields inconclusive results.
Src-family kinases are a group of non-receptor tyrosine kinases. Thus in an
attempt to develop a control for Src-family kinase inhibition with PP2, I examined the
effects of broad tyrosine protein kinase inhibition on adenoviral transduction using
genistein (a broad tyrosine protein kinase inhibitor). CaLu-3 cells were treated with
either DMSO (control) or increasing doses of genistein for 1 h. The treated cells were
then infected with adenovirus carrying the β-galactosidase reporter gene (MOI 100) for 1
h, then washed and replenished with standard culture media containing the chemical
inhibitor. The cells were analyzed 24 h later via a β-galactosidase assay. The CaLu-3
cells showed a broad range of results (Fig. 29; p<0.001). At lower concentrations of
genistein, adenovirus infection was diminished, however, at higher concentrations of
genistein, viral infection increased. From these data, it was determined that genistein has
multiple effects on viral infection that deserves future attention, but is not an ideal
control.
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Figure 29. Broad inhibition of tyrosine kinases yields broad range in results.
CaLu-3 cells were treated with genistein, a tyrosine protein kinase inhibitor, for 1
h then transduced with AdV-β-Gal (MOI 100) for 1 h. Cells were washed and
replenished with standard growth media containing chemical inhibitor over
night. β-galactosidase assay was performed 24 h later after transduction. β-Gal
activity was assessed for four wells of cells per conditions by β-galactosidase
assay. Error bars indicate standard error of the mean (SEM). (* = P < 0.0001;
One-Way ANOVA; Tukey’s Post Hoc Test).
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4.3 Conclusion
From these data, I have shown that Src-family kinases do in fact play a role in
adenovirus infection. Here I show that inhibiting Src-family kinases decreases viral
infection in a dose dependent manor and at an early stage of infection. Alternatively, we
show that extended Src-family kinase inhibition with PP2 further decreases both viral
infection and CAREx8 expression at later time points. However, CAREx8 expression
remains unaffected by PP2 at early time points.
We then narrowed our scope and asked if adenovirus binding activates c-Src
kinase specifically. Here we show that c-Src kinase is activated within the first 60
minutes of adenovirus infection. Knowing that adenovirus activates c-Src kinase, and the
inhibiting Src-family kinases decreases viral infection, we then asked if activating Srcfamily kinases would help facilitate adenovirus infection or increase CAREx8 expression.
However, activating Src-family kinases neither increased nor decreased viral infection or
CAREx8 expression.
Lastly, we show that c-Src kinase is one of the specific family members involved
in adenoviral infection. This was shown by using a shRNA exclusively directed against
c-Src kinase, which led to a substantial decrease in adenoviral infection. It can be
concluded that c-Src kinase plays a role relatively early on in adenoviral infection,
although after viral entry.

Based on this data, one can state that c-Src is crucial for

efficient viral transduction.
The limitation within the experimental designs lay with the conditional
parameters such as the chemical inhibitors, activators, and controls used. PP1 and PP2
are small molecule chemical inhibitors for Src-family kinases. Src-family kinases are
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composed of nine family members, however these inhibitors are only specific to a few of
the family members, and have varying specificities (Table 3 and 4). Recently, a kinome
study suggested that PP2 at a concentration of 10 µM was not that selective, showing that
multiple kinases were displaced by an immobilized ligand bound by PP2 [48]. This
suggests that PP2 has several off-site targets which may be affecting the results. The Src
activator used is a YEEI phosphopeptide that binds the SH2 domain of Src-family
kinases. SH2 domains are conserved among the Src-family members, and are responsible
for recognizing and binding phosphor-tyrosine sequences on other proteins [49]. It is
possible that the activator binding the SH2 domain blocks potential interactions with
other proteins, thus rendering the kinase inactive for adenovirus infection. Constitutively
active Src-family kinases, by mutating the Y527 at the c-terminus of each family
member, may serve as better approach to determine activated Src-family kinases role in
CAR expression and adenoviral entry in the future.
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Chapter 5. Discussion
5.1 CAR Half life
Protein turnover plays an important role in cellular processes. Knowing the rate
at which a protein is degraded can have significant implications for the advancement of
directed therapeutics in treating certain diseases.
mechanisms of how the protein is degraded.

It also provides insight into the

In instances where there are several

different isoforms of a protein, with differential localization of each separate isoform, and
a varied concentration of each isoform under standard cellular conditions, knowing the
half-life of each isoform could lend some understanding into protein function and
regulation. Here we show that the half-life of CAREx7 is roughly 5 h whereas CAREx8 is
roughly 2 h in polarized MDCK stable cells. This is interesting in that CAR acts as the
primary receptor for both the coxsackie B virus and most adenoviruses. Specifically each
CAR isoform has a distinct localization in polarized epithelial cells. CAREx7 localizes at
the basolateral surface where CAREx8 localizes at the apical surface or resides in
subapical compartments [9]. Each CAR isoform has been shown to interact with MAGI1b [22, 50]. Interestingly, the PDZ1 and PDZ3 domains of MAGI-1b have been shown
to play differential roles in CAREx8 regulation.
In this study we show that the two isoforms of CAR have varied half-lives. This
makes sense when put into context of structure and function within the cells. CAREx7 is
important for maintaining epithelial polarity at the basolateral surface by forming
homophilic adhesions with corresponding CAREx7 molecules on adjacent cells. These
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CAR-CAR-mediated hemophilic interactions between cells are thought to increase tight
junction integrity [11, 13]. CAREx7 plays a critical role in neutrophil transepithelial
migration by interacting with junction adhesion molecule like protein (JAM-L), an
adhesion protein on the surface of neutrophils [51].
In contrast, the function of CAREx8 and its role at the apical surface is still largely
a mystery.

Since CAREx8 is capable of acting as the primary receptor for most

adenoviruses, its unique localization at the apical surface of polarized airway epithelia
provides an ideal opportunity for adenoviruses entering the lumen of the airway to initiate
infection. It therefore makes logical sense for this particular isoform to be more tightly
regulated, less abundant, and have a shorter half-life to protect the cells from viral
infection.
The regulation of each CAR isoform begins at the transcript level, which
translates into further regulation at the protein level. MAGI-1b acts as a scaffolding
protein that interacts with the junctional proteins ZO-1, β-catenin, and CAREx7 [50, 52,
53]. The longer half-life of CAREx7 could be attributed to it being a more functionally
stable protein within complexes at the basolateral junctions, or varying protein
interactions, including a stabilizing interaction with the scaffolding protein MAGI-1b at
the tight junctions, or homophilic adhesion to other CAREx7 proteins on adjacent cells. In
contrast, CAREx8 has been shown to be negatively regulated by MAGI-1b and it is not yet
known whether it is part of a protein complex when at the apical surface. This could
account for decreased protein stability thus a shorter half-life.
The short half-life of CAREx8 may also be a consequence of the protein’s native
physiological role in neutrophil transmigration, a process that only requires CAREx8 to be
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expressed in short transient bursts. Recently it has been shown that the chemokine
interlukin-8 (IL-8) increases CAREx8 expression at the apical surface of polarized
epithelia [21].

In instances of potential infection in the airway, IL-8 serves as a

chemoattractant, recruiting neutrophils to the site of infection. Moreover, recent data
from our lab suggest that CAREx8 is able to tether infiltrating neutrophils at the apical
surface of the epithelium. Although this would increase the critical concentration of
neutrophils and increase the killing of invading pathogens, prolonged residence on the
epithelium may damage the host cells. A short half-life would limit the time of
neutrophils at the apical surface and limit host-cell damage.

5.2 CAR and Src-kinases
Cell signaling is a complex communication system that controls nearly every
function within a cell. Signaling cascades are generated from the cells ability to sense and
respond to external and internal environmental stimuli. The ability for a cell to detect and
react to changes within its external environment is critical for many essential processes
such as growth and development, tissue repair, and immunity. A defect in a cells ability
to interact and respond to its environment can lead to the development of many diseases
including cancer, AIDS, and autoimmune disorders. Understanding specific signaling
cascades has major implications for understanding virus pathogenicity and has the
potential to provide a platform for researchers to develop site directed therapeutics in
order to treat certain diseases or prevent viral egress in infected individuals.
Recently Src-family kinases have been shown to play a role in viral infection and
have been shown to interact with CAR at cell junctions and in sertoli germ cells [28, 33,
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54]. It is also known that these kinases are involved in many cell signaling pathways
[55]. Here I have shown that Src-family kinases do in fact play a role in the early stages
of viral infection. When Src-family kinases are inhibited, viral infection is limited or
decreased, however the converse is not true. Upregulation of Src-family kinases does not
result in an increase in viral infection. I hypothesized that Src kinase inhibition decreased
CAREx8 expression, however, when Src kinases were inhibited with PP1 or PP2, there
was no detectable change in total CAREx8 levels at early time points. Interestingly
enough extended exposure to PP2 for more than 8 h showed a mild decrease in CAREx8
expression and a substantial decrease in viral genomes entering the cells. Even further
exposure to PP2 for 24 h showed a more pronounced decrease in CAREx8 expression and
adenovirus entry. These occurrences may be specific and distantly regulate CAREx8
expression. Alternatively, they may be due to off-site targeting of the chemical inhibitor
instead of decreased Src-family kinase activity. Off-target effects can be supported by
the fact that when using shRNA specific for c-Src, there was no change in CAREx8
expression in HeLa cells. However, PP2 is a broad small molecule inhibitor for Srcfamily kinases. Potentially the changes we see in cells that have had extended exposure
to PP2 is either due to off-site targeting, or due to the inhibition of an alternative Srcfamily kinase One such family is Hck and c-Src. This stems from the fact that decreased
CAREx8 expression was limited to PP2 alone, whereas PP1 showed no change. As shown
in Tables 3 and 4 the largest variance between the two small molecule inhibitors lies in
the concentration of inhibitor needed to reduce the response or binding of the target by
half (IC50) were for Hck and c-Src. PP1 has an IC50 for Hck = 20 nM and c-Src = 170
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Table 3. PP1 affinity for kinase targets.
PP1 target

Affinity (IC50)

Src-family kinase

Lck

5 nM

+

Fyn

6 nM

+

Hck

20 nM

+

Src

170 nM

+

EGFR

250 nM

-

JAK2

50,000 nM

-

ZAP-70

600 nM

-
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Table 4. PP2 affinity for kinase targets.
PP2 target

Affinity (IC50)

Src-family
kinase

Lck

4 nM

+

Fyn

5 nM

+

Hck

5 nM

+

Src

100 nM

+

EGFR

480 nM

-

JAK2

50,000 nM

-

ZAP-70

100,000 nM

-
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nM, whereas PP2 has an IC50 for Hck = 5 nM and c-Src = 100 nM (Bertin Pharma;
Table 3 and 4) [56]. Even though viral entry and transduction were decreased by both
PP1, PP2 and c-Src shRNA, Hck kinase may actually play a role in CAREx8 expression
since c-Src shRNA had no effect on CAREx8 expression.
Despite no to limited late changes in CAREx8 protein expression, viral entry and
transduction were decreased by both PP1 and PP2 and were decreased by the c-Src
shRNA. This suggests that the changes in adenoviral infection are directly correlated to
Src inhibition. Src has been shown to be involved with dynamin-mediated endocytosis
and macropinocytosis. Recently, Morton et al., suggest that CAR potentially mediates Src
signaling and that inhibiting Src with PP2 decreases CAR localization to vesicles.
Alternatively, when Src is not being inhibited, it has been shown to localize with CAR at
the cell junctions and in vesicles.

Adenovirus enters cells via receptor-mediated

endocytosis in clathrin coated vesicles. Due to CAR being the primary receptor for most
adenoviruses, this suggests that Src activity is required for the adequate endocytosis of
CAR-AdV. Which has further implications because when Src is inhibited or silenced,
adenovirus is unable to be internalized by the host cells thus leading to decreased viral
transduction.
Alternatively, Src inhibition was shown to redirect reovirus to the lysosome at an
early point of infection where it was unable to replicate. Here I show that, Src kinase
inhibition only affects adenoviral transduction within the first hour after viral infection.
There was no change in viral transduction efficiency when Src was inhibited prior to viral
infection but not immediately after infection. Additionally, inhibiting Src-family kinases
1 h after the initial infection period did not affect viral transduction efficiency. This
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suggests that Src kinases play a critical role during viral trafficking. Thus, inhibiting Src
family kinases interrupts the ability of adenoviruses to successfully travel to the nucleus,
instead potentially trafficking the virus to the lysosome where it is then degraded.

5.3 Broader impacts and future studies
In human polarized epithelial cells, CAREx8 localizes to the apical surface where it
is accessible for viral infection. Preliminary data shows that the inhibition of Src-family
kinase using the small molecule inhibitor PP2 decreases adenoviral infection. This
research will help narrow down which endogenous mechanisms regulate CAR expression
and localization. Insight may be provided to future researchers as well as medical
professionals as to why a viral receptor would localize at the apical surface of epithelia a high-risk area for viral contact upon the inhalation of droplets that potentially contain
viruses suspended in the air (i.e. sneezes).

Identification and investigation of the

signaling pathways involved in adenoviral entry from the airway lumen will allow for the
identification of novel therapeutic targets that can 1) aid in the advancement of
adenoviral mediated gene therapy to treat lung disorders such as cystic fibrosis and
asthma; and 2) aid in mapping out a way to decrease the susceptibility of the population
to adenoviral infections

Future directions
Preliminary data strongly supports the hypotheses that the Src family kinases are
involved with adenoviral infection but do not acutely affect CAREx8 expression. If the
inhibition of Src family kinases proves to not play a role in the trafficking of internalized
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virus, then an alternative hypothesis would be that the Src family kinases are involved
with integrin localization and/or cell signaling. Src family kinases may also play a role in
viral disassembly or viral DNA expression (Fig. 30). If the MDCK stable cells prove to
not be an ideal model of CAREx8 expression, turnover, and degradation, then other
avenues

involving

radiolabeled

endogenous
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Figure 30. Model of Src-family kinase inhibition hypotheses.
Inhibiting Src-family kinases does one or a combination of the following: 1.
Ex8
Decreases CAR
at the apical surface of polarized epithelia. 2. Inhibits
internalization of bound virus. 3. Targets internalized virus to the lysosome.
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